Health & Biotech
Pot stock MGC Pharma is racing into Brazil with new distribution deal
Kiwi pot stock Cannasouth hits the boards in New Zealand; shares dive
Biotech: Orthocell proves again we live in the future, with dental bone regeneration tech
Biotech: Medlab lands another clinical trial for its cannabis mouth spray
The Pot Seat distilled: The 9 key things we know now about Aussie cannabis
Health: Milk maker Keytone upsizes in Vic for $53m; Tas poppy war ends peacefully
Dr Boreham’s Crucible: Expectations are high as Heramed waits to pop in the US
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Medicinal cannabis distributors are loving what MGC is selling
Pot stock THC just got a manufacturing licence for its Bundaberg plant
Feeling chubby? Check out these obesity-blasting ASX stocks
The Pot Seat: Eve’s Ben Rohr says cannabis honey could be a thing in 2021
Dr Boreham’s Crucible: Medical Developments is finding ways to gain without US pain
Canadian shareholder buys Aussie pot stock Creso Pharma for $122m
PKS dips on debut as profitability isn’t enough to lasso investors
Elixinol raises another $50m, bringing its total fundraising to $120m in 18 months
Cannabis: Here come the hemp licences – Althea, Murray River get the green tick
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
